Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Business Wire
Moderna announces New Drug Application submitted to import and distribute Moderna’s COVID-19 vaccine candidate in Japan.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan. TAK-919 is Takedas development code for Modernas COVID-19 vaccine candidate.
Submitting…
-
General18 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
Business16 hours agoUp 48% in a month, can Domino’s Pizza shares keep the momentum going?
-
Business18 hours ago3 reasons why the Vanguard MSCI Index International Shares ETF (VGS) is a top buy
-
Noosa News15 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months